The fund will primarily target mid- to late-stage life science companies. Since its 2012 founding, Cowen has invested in more than 60 healthcare companies, according to a May 3 Cowen Healthcare news release.
“With Cowen Healthcare Investments expanding its investment tools to now allow it to invest in the public markets, this new fund, CHI IV, will further capture value creation opportunities by seizing upon attractive entry points generated by regular market volatility,” Elizabeth Flisser Rosman, head of Cowen Investment Management, said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
